LDS/Medical Tests/Solute Carrier Family 22 (SLC22A5) Gene Mutation Analysis

Solute Carrier Family 22 (SLC22A5) Gene Mutation Analysis

The Solute Carrier Family 22 Member 5 (SLC22A5) gene located at 5q31.1 codes for polyspecific organic cation transporters (OCTN2) which are found in the heart, muscle, liver, kidney, intestine, and other organs. These transporters are important for the intracellular transportation of carnitine as well as the elimination of endogenous small organic cations and environmental toxins. Carnitine is an essential component for the beta-oxidation of long-chain fatty acids transferred from the cytoplasm to the mitochondria. Fatty acids are the primary substrate for energy generation in the liver, cardiac muscle, and skeletal muscle when glucose levels are low.

Mutations in SLC22A5 gene results in a deficiency of OCTN2 activity resulting in urinary carnitine wasting, low plasma carnitine levels, and decreased intracellular carnitine accumulation. Fatty acid oxidation is impaired by low carnitine levels which result in hypoglycemia and the accumulation of fat in the liver, skeletal muscle, and heart, causing steatosis and myopathy.

  • Confirms diagnosis of carnitine transporter deficiency
  • Screening individuals with a family history of primary carnitine deficiency

A positive result indicates the presence of mutations or pathogenic variants in the SLC22A5 gene thus indicating carnitine transporter deficiency.

A negative result indicates the absence of mutations or pathogenic variants in the SLC22A5 gene.

Negative for mutations analyzed (No mutations or pathogenic variants detected)

Allele Specific Primer Extension (ARMS) by Real-time Polymerase chain reaction (PCR), Next generation sequencing (NGS), Conventional Sequencing.

Whole blood collected in EDTA (Lavender top tube).

Stability

  • Room: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unstable
Plasma carnitine level, fasting plasma glucose, Carnitine-Acylcarnitine Translocase Deficiency, Gene Mutation, Carnitine Palmitoyltransferase 1A (CPT1A) Mutation.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Orphanet J Rare Dis. 2012 Sep 18;7:68. [PMID: 26075114]
  • Mol Genet Metab. 2010 May;100(1):46-50. [PMID: 20074989]
  • J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):879-883. [PMID: 28753539]
  • Zhongguo Dang Dai Er Ke Za Zhi. 2017 Nov;19(11):1150-1154. [PMID: 29132460]
  • GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 22420015]